Addus HomeCare Corp

For the period ended Nov 3, 2026. Filed Nov 3, 2026.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 3, 2026 · Filed Nov 3, 2026

Use the contents to explore the available documents and sections.

ADUS$124.31-2.0%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.1 · Footnotes:

Footnotes:

(1) The average billable census in acquisitions of 14,024 and 14,292 for the three months and nine months ended September 30, 2025, was reclassified to average billable census - same stores for comparability purposes.

(2) The average billable census for closed stores of 46 and 53 for the three months and nine months ended September 30, 2025 was reclassified to average billable census - closed stores for comparability purposes.

(3) Revenue organic growth reflects the change in year-over-year revenue for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of one-time adjustments such as ARPA, Medicare cap or specific situational reserves as well as acquisitions, new store openings, and closures.

(4) Exited sites would have reduced ADC for the three months ended September 30, 2025, by 6 and the nine months ended September 30, 2026, and September 30, 2025, by 2 and 6, respectively.

-MORE-

Reconciliation of Non-GAAP Financial Measures

(Amounts in thousands, except per share data)

(Unaudited) (1)

· · For the Three MonthsEnded September 30, · · · For the Nine MonthsEnded September 30, ·
· · 2026 · · · 2025 · · · 2026 · · · 2025 ·
Reconciliation of Adjusted EBITDA to Net Income: (1)

Net income	$28,594	$22,848	$81,270	$66,128

Interest expense, net	678	2,583	3,477	9,041
(Gain) loss on sale of assets	(33)	2	(46)	(6)
Income tax expense	10,546	7,506	28,085	21,169
Depreciation and amortization	4,138	4,408	12,293	12,264
Acquisition expenses	3,948	2,012	6,738	7,672
Stock-based compensation expense	3,008	4,286	12,398	11,877
Restructure and other non-recurring costs	370	1,500	715	1,500
Adjusted EBITDA	$51,249	$45,145	$144,930	$129,645


Reconciliation of Adjusted Net Income to Net Income: (2)

Net income	$28,594	$22,848	$81,270	$66,128

(Gain) on sale of assets	(33)	2	(46)	(6)
Acquisition expenses	3,948	2,012	6,738	7,672
Stock-based compensation expense	3,008	4,286	12,398	11,877
Restructure and other non-recurring costs	370	1,500	715	1,500
Tax Effect	(1,961)	(1,925)	(5,086)	(5,103)

Adjusted Net Income	$33,926	$28,723	$95,989	$82,068


Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)

Net income per diluted share	$1.54	$1.24	$4.39	$3.60

Acquisition expenses per diluted share	0.16	0.08	0.27	0.32
Stock-based compensation expense per diluted share	0.12	0.18	0.50	0.50
Restructure and other non-recurring costs per diluted share	0.01	0.06	0.03	0.06

Adjusted net income per diluted share	$1.83	$1.56	$5.19	$4.48

Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)

Net service revenues	$387,733	$362,301	$1,128,761	$1,049,452

Revenues associated with the closure of certain sites	3	(1,268)	(109)	(3,420)

Adjusted net service revenues	$387,736	$361,033	$1,128,652	$1,046,032

Reconciliation of Adjusted Hospice Organic Revenue Growth: (5)

Hospice Revenue	$69,022	$68,891
Exclusions from organic revenue	1,419	(1,241)
As reported Hospice organic revenue growth	$70,441	$67,650	4.1%
Implicit price concessions	1,519	(1,495)
Adjusted Hospice organic revenue growth	$71,960	$66,155	8.8%

-MORE-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.